Inhibitex INHX +140.1% on takeover announcement from Bristol-Myers Squibb
Idenix Pharmaceuticals IDIX +37% on positive Hepatitis drug results
Achillion Pharmaceuticals ACHN +22.7% on positive clinical data
IPC Hospitalist Company IPCM -33% on poor Q4 EPS and revenue guidance
Perfect World Co PWRD -26.6% on heavy volume
Theravance THRX -18.9% after losing contract with Astellas
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsBroad U.S. Equity ETFsEventsGlobalEconomicsAfter-Hours CenterMarketsMoversReviewsETFs
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in